Search results
DHR Health in Edinburg announces new hours for vaccine clinic
KRGV Rio Grande Valley· 4 days agoDHR Health is offering first, second and third doses of the Pfizer vaccine at a clinic running until...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoUsually, RSV causes coldlike symptoms in most people. But in newborns and older adults it can be...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 23 hours agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
The chicken and egg problem of fighting another flu pandemic
Oregon Capital Chronicle via Yahoo News· 10 hours agoEven a peep of news about a new flu pandemic is enough to set scientists clucking about eggs. They...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 2 days agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 1 day agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
WGRZ-TV Buffalo· 6 days agoGovernment officials still say the benefits of the shots outweigh the risks. Health officials have...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 2 days agoA long-term analysis, extending over 8.6 months median follow-up, found that...enter the US market...
Structure patches up holes in share price after GLP-1 linked to 6% weight loss
FierceBiotech· 5 days agoAfter investors frowned on Structure Therapeutics’ oral GLP-1 data in December 2023, the biotech is...